Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1840371000001117 | Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1840381000001115 | Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Is a | Aztreonam 75mg powder and solvent for nebuliser solution vials with device | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has active ingredient | Aztreonam | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has specific active ingredient | Aztreonam lysine | false | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has dispensed dose form | Powder and solvent for nebuliser solution | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Aztreonam | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Is a | Cayston | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has manufactured dose form | Powder and solvent for nebuliser solution | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has basis of strength substance | Aztreonam | true | Inferred relationship | Existential restriction modifier | ||
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Has specific active ingredient | Aztreonam lysine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) 84 vial | Has AMP | True | Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR